JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

JNJ

238.71

-0.54%↓

UNH

277.86

+0.52%↑

TMO

542.43

+0.07%↑

ABT

110.77

-0.05%↓

ISRG

493.16

+1.21%↑

Kodu・Aktsiate loetelu・Celsion Corp

Celsion Corp

Avatud

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

Max

Põhinäitajad
By Trading Economics
Töötajad	25

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+465.75% upside

Turustatistika
By TradingEconomics
Turukapital	938K
Eelmine avamishind	0
Eelmine sulgemishind	0

Celsion Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

8. veebr 2026, 23:57 UTC

Market Talk

Uranium Outlook Heats Up on Rising Demand, Uncertain Supply -- Market Talk

8. veebr 2026, 23:47 UTC

Market Talk

Gold Rises Amid Growing U.S.-Iran Tensions -- Market Talk

8. veebr 2026, 23:43 UTC

Market Talk

Nikkei Likely to Rise Sharply After Takaichi's Election Win -- Market Talk

8. veebr 2026, 23:34 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. veebr 2026, 23:34 UTC

Market Talk

Landslide Election Victory of Japan's LDP Positive for Risk Assets -- Market Talk

8. veebr 2026, 23:26 UTC

Market Talk

Yen Skittish; Nikkei Jumps On LDP Landslide -- Market Talk

8. veebr 2026, 22:55 UTC

Tulu

DBS Group 4Q Net S$2.36B Vs. Net S$2.62B >D05.SG

8. veebr 2026, 22:55 UTC

Tulu

DBS Group 4Q Net Interest Income S$3.59B Vs. S$3.83B>D05.SG

8. veebr 2026, 22:55 UTC

Tulu

DBS Board Proposes 4Q Dividend of 66 Singapore Cents/share>D05.SG

8. veebr 2026, 22:55 UTC

Tulu

DBS Group: 2025 Total Dividend at S$3.06/share >D05.SG

8. veebr 2026, 22:55 UTC

Tulu

DBS Group 4Q Net Weighed by Higher Tax Expense, Absence of Non-Recurring Gains Recrorded Last Year >D05.SG

8. veebr 2026, 22:55 UTC

Tulu

DBS Group 4Q Total Income S$5.33B Vs. S$5.51B>D05.SG

8. veebr 2026, 21:43 UTC

Market Talk

FX Intervention Watch Resumes After Japan Election Result -- Market Talk

8. veebr 2026, 21:16 UTC

Market Talk

Right Of Australian Politics Reshaped as One Nation Surges -- Market Talk

8. veebr 2026, 21:15 UTC

Market Talk

Japan's Election Outcome to Revive Takaichi Trade -- Market Talk

7. veebr 2026, 09:20 UTC

Market Talk

Financial Services Roundup: Market Talk

7. veebr 2026, 09:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

7. veebr 2026, 05:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

7. veebr 2026, 02:46 UTC

Omandamised, ülevõtmised, äriostud

Big Money, High Anxiety -- Barrons.com

6. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. veebr 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6. veebr 2026, 21:40 UTC

Omandamised, ülevõtmised, äriostud

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6. veebr 2026, 21:22 UTC

Market Talk

Mexico's Inflation Seen Accelerating in January -- Market Talk

6. veebr 2026, 21:17 UTC

Tulu

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6. veebr 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. veebr 2026, 21:14 UTC

Omandamised, ülevõtmised, äriostud

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6. veebr 2026, 21:13 UTC

Tulu

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6. veebr 2026, 21:13 UTC

Tulu

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6. veebr 2026, 21:04 UTC

Market Talk

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6. veebr 2026, 20:34 UTC

Tulu

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Celsion Corp Prognoos

Hinnasiht

By TipRanks

465.75% tõus

12 kuu keskmine prognoos

Keskmine 18.5 USD 465.75%

Kõrge 25 USD

Madal 12 USD

Põhineb 2 Wall Streeti analüütiku instrumendi Celsion Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

2 ratings

Osta

Hoia

Müü

Põhineb 2 analüütiku instrumendi Celsion Corp aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Ettevõttest Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.